Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus. [electronic resource]
- Diabetes, obesity & metabolism 01 2017
- 24-32 p. digital
Publication Type: Journal Article
1463-1326
10.1111/dom.12752 doi
Administration, Oral Adult Aged Alkanesulfonates--pharmacology Benzamides--pharmacology Blood Glucose--drug effects Diabetes Mellitus, Type 2--metabolism Fasting Female Glucagon--drug effects Glucose Tolerance Test Glycated Hemoglobin--metabolism Healthy Volunteers Humans Hypoglycemia--chemically induced Male Middle Aged Postprandial Period Receptors, Glucagon--antagonists & inhibitors Young Adult